MX2017009343A - Uso de taurina en la prevención y/o el tratamiento de enfermedades inducidas por virus del género coronavirus y/o del género rotavirus. - Google Patents

Uso de taurina en la prevención y/o el tratamiento de enfermedades inducidas por virus del género coronavirus y/o del género rotavirus.

Info

Publication number
MX2017009343A
MX2017009343A MX2017009343A MX2017009343A MX2017009343A MX 2017009343 A MX2017009343 A MX 2017009343A MX 2017009343 A MX2017009343 A MX 2017009343A MX 2017009343 A MX2017009343 A MX 2017009343A MX 2017009343 A MX2017009343 A MX 2017009343A
Authority
MX
Mexico
Prior art keywords
coronavirus
taurine
preventing
application
treating disease
Prior art date
Application number
MX2017009343A
Other languages
English (en)
Inventor
Huang Zhipeng
Zhu Shifa
Cao Jiyuan
Cheng Wen
Wang Yongdong
Original Assignee
Genifarm Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genifarm Laboratories Inc filed Critical Genifarm Laboratories Inc
Publication of MX2017009343A publication Critical patent/MX2017009343A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

En la presente invención se proporciona el uso de taurina para prevenir y/o tratar enfermedades inducidas por un virus del género coronavirus y/o del género rotavirus, tales como diarrea epidémica porcina, gastroenteritis porcina transmisible, diarrea por rotavirus y similares.
MX2017009343A 2015-01-17 2015-01-17 Uso de taurina en la prevención y/o el tratamiento de enfermedades inducidas por virus del género coronavirus y/o del género rotavirus. MX2017009343A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2015/070953 WO2016112552A1 (zh) 2015-01-17 2015-01-17 牛磺酸在预防和/或治疗由冠状病毒属和/或轮状病毒属病毒引发的疾病中的应用

Publications (1)

Publication Number Publication Date
MX2017009343A true MX2017009343A (es) 2017-11-15

Family

ID=56405151

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017009343A MX2017009343A (es) 2015-01-17 2015-01-17 Uso de taurina en la prevención y/o el tratamiento de enfermedades inducidas por virus del género coronavirus y/o del género rotavirus.

Country Status (14)

Country Link
US (1) US10314799B2 (es)
EP (1) EP3246024B1 (es)
JP (1) JP6444515B2 (es)
KR (1) KR101969007B1 (es)
BR (1) BR112017015340B1 (es)
CA (1) CA2974024C (es)
DK (1) DK3246024T3 (es)
ES (1) ES2758674T3 (es)
MX (1) MX2017009343A (es)
PH (1) PH12017550047A1 (es)
PL (1) PL3246024T3 (es)
RU (1) RU2678105C2 (es)
UA (1) UA120066C2 (es)
WO (1) WO2016112552A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109223716B (zh) * 2018-09-03 2020-10-30 北京普飞特生物科技有限公司 一种抗猪流行性腹泻、猪瘟、伪狂犬和传染性胃肠炎的四联卵黄抗体可溶性粉及其制备方法
WO2021240375A1 (en) * 2020-05-26 2021-12-02 Blueprint Pharma S.R.L. Methotrexate for use in the pharmaceutical or veterinary prevention and/or treatment of viral infections
IT202000012325A1 (it) * 2020-05-26 2021-11-26 Blueprint Pharma Srl Metotrexato per l’uso nel trattamento di infezioni virali in animali da allevamento
CN115350170B (zh) * 2022-08-29 2023-08-29 浙江省农业科学院 牛磺酸在制备提高中华鳖抗病毒性腮腺炎病能力的药物中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000044473A (ja) * 1998-07-27 2000-02-15 Mitsui Norin Co Ltd 家畜のウイルス感染予防剤
AU2003900064A0 (en) * 2003-01-09 2003-01-23 Penam Investments Pty. Ltd. A method of treatment or prophylaxis of viral infection.
KR100419191B1 (ko) * 2003-06-23 2004-02-19 주식회사 엔바이오테크놀러지 독감 인플루엔자 바이러스 및 전염성 위장염 코로나바이러스 억제 활성을 갖는 효모변이주 아이에스2 유래수용성 글루칸 올리고머를 함유하는 조성물
US7879030B2 (en) * 2005-07-27 2011-02-01 St. Jude Medical, Atrial Fibrillation Division, Inc. Multipolar, virtual-electrode catheter with at least one surface electrode and method for ablation
KR100720151B1 (ko) * 2005-12-13 2007-05-18 한국생명공학연구원 항바이러스 활성을 갖는 플라보노이드 화합물
CN101869151B (zh) * 2010-07-08 2012-07-04 湖南澳优食品与营养研究院 一种含乳凝集素的婴幼儿奶粉及其制备方法
CN101966245B (zh) * 2010-10-13 2011-11-30 郑州后羿制药有限公司 一种治疗畜禽病毒性疾病的复方注射液及其制备方法
CN103006811B (zh) * 2012-12-29 2014-02-19 潍坊富邦药业有限公司 一种撒在初生仔猪的体表预防疾病的方剂及制备工艺
CN103341160B (zh) 2013-02-27 2015-11-11 澳蒲生物科技(上海)有限公司 一种含有干扰素的药物组合物及其应用
US9283250B2 (en) 2013-03-14 2016-03-15 Ag Odor Control, LLC Oral administration of electrolyzed water for treatment and prevention of PEDv in swine, swine herds and swine confinements
CN103127416B (zh) 2013-03-22 2014-11-26 刘荣彬 一种预防和治疗猪传染性胃肠炎和流行性腹泻的药物
CN103230574B (zh) 2013-04-25 2014-09-17 中国农业科学院兰州畜牧与兽药研究所 一种治疗猪流行性腹泻的中药组合物及其应用
CN103417570A (zh) * 2013-08-30 2013-12-04 天津生机集团股份有限公司 用于治疗猪细菌腹泻的组合物及其制备方法

Also Published As

Publication number Publication date
RU2017125426A (ru) 2019-01-18
WO2016112552A1 (zh) 2016-07-21
PH12017550047B1 (en) 2018-02-05
BR112017015340A2 (pt) 2018-01-09
EP3246024A1 (en) 2017-11-22
EP3246024A4 (en) 2018-10-24
DK3246024T3 (da) 2019-12-09
CA2974024C (en) 2020-01-21
CA2974024A1 (en) 2016-07-21
RU2678105C2 (ru) 2019-01-23
KR101969007B1 (ko) 2019-04-15
EP3246024B1 (en) 2019-09-25
UA120066C2 (uk) 2019-09-25
JP2018501294A (ja) 2018-01-18
RU2017125426A3 (es) 2019-01-18
ES2758674T3 (es) 2020-05-06
BR112017015340B1 (pt) 2022-10-11
PH12017550047A1 (en) 2018-02-05
JP6444515B2 (ja) 2018-12-26
US10314799B2 (en) 2019-06-11
PL3246024T3 (pl) 2020-03-31
US20170368006A1 (en) 2017-12-28
KR20170106962A (ko) 2017-09-22

Similar Documents

Publication Publication Date Title
CL2018001181A1 (es) Inhibidores de ret
BR112018004620A2 (pt) moduladores da expressão de kras
CO2020004202A2 (es) Compuestos químicos
CL2017000285A1 (es) Terapia combinada para el tratamiento de un paramixovirus
CL2016000839A1 (es) Composiciones para modular la expresión de c9orf72.
PH12016501873A1 (en) Anti-influenza b virus hemagglutinin antibodies and methods of use
PH12016502062A1 (en) Compositions and methods for modulating completent factor b expression
PH12021550558A1 (en) Modulators of pnpla3 expression
PH12017550047A1 (en) Use of taurine in prevention and/or treatment of diseases induced by viruses of genus coronavirus and/or genus rotavirus
PH12019502174A1 (en) Modulators of pcsk9 expression
HK1259323A1 (zh) 治療、預防和診斷豬流行性腹瀉病毒感染的方法
PH12018502233A1 (en) ErbB INHIBITORS AND USES THEREOF
UY36217A (es) Compuestos piridona sustituídos, composiciones farmacéuticas y métodos de uso.
MX2016009597A (es) Terapias para el influenzavirus a subtipo h7n9.
EA201990064A1 (ru) Противомалярийные композиции и варианты их применения
EA201692569A1 (ru) Полимиксины с низкой степенью замещения и композиции, их содержащие
CO2020003134A2 (es) Moduladores de la expresión de enac
MX2023009895A (es) Compuestos y composiciones para tratar la fibrosis.
MX2023008764A (es) Composiciones y metodos para prevenir y tratar afecciones.
UA104897U (uk) Засіб "ектоцид-плюс" для боротьби з комплексом гнусу
IT201700023051A1 (it) Serratura antiscasso
UA108340U (uk) Морфолінію 1-н-бутилтеобромін-8-ілтіоацетат, який виявляє діуретичну дію
UA92410U (ru) Способ формирования панкреатоеюноанастомоза
UA112287U (xx) Застосування вінборону для нівелювання антипроліферативного впливу ібупрофену на шлунковий епітелій
TN2014000522A1 (fr) لوح مدرسي بوجهين